<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2681287-A1" country="EP" doc-number="2681287" kind="A1" date="20140108" family-id="46797354" file-reference-id="296091" date-produced="20180823" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146586979" ucid="EP-2681287-A1"><document-id><country>EP</country><doc-number>2681287</doc-number><kind>A1</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-12755046-A" is-representative="NO"><document-id mxw-id="PAPP154849171" load-source="docdb" format="epo"><country>EP</country><doc-number>12755046</doc-number><kind>A</kind><date>20120305</date><lang>EN</lang></document-id><document-id mxw-id="PAPP174953059" load-source="docdb" format="original"><country>EP</country><doc-number>12755046.5</doc-number><date>20120305</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140551919" ucid="CA-2012000195-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>CA</country><doc-number>2012000195</doc-number><kind>W</kind><date>20120305</date></document-id></priority-claim><priority-claim mxw-id="PPC140557571" ucid="US-201161449389-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>201161449389</doc-number><kind>P</kind><date>20110304</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL-2051729320" load-source="docdb">B68G   7/12        20060101ALI20150520BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-2051730631" load-source="docdb">B29C  73/10        20060101ALI20150520BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-2051730988" load-source="docdb">C09J   7/02        20060101AFI20150520BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-2051731379" load-source="docdb">A61L   2/16        20060101ALI20150520BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-2051732168" load-source="docdb">A61G   7/05        20060101ALI20150520BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-2051733813" load-source="docdb">A47C  31/00        20060101ALI20150520BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-1713572772" load-source="docdb" scheme="CPC">C09J   7/22        20180101 LI20180103BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2102483900" load-source="docdb" scheme="CPC">Y10T 428/24959     20130101 LA20150123BCEP        </classification-cpc><classification-cpc mxw-id="PCL-2102484756" load-source="docdb" scheme="CPC">Y10T 428/20        20130101 LA20150123BCEP        </classification-cpc><classification-cpc mxw-id="PCL1989621545" load-source="docdb" scheme="CPC">B29C  73/10        20130101 LI20130915BHEP        </classification-cpc><classification-cpc mxw-id="PCL1989625316" load-source="docdb" scheme="CPC">C09J2433/00        20130101 LA20130915BHEP        </classification-cpc><classification-cpc mxw-id="PCL1989636483" load-source="docdb" scheme="CPC">C09J2201/622       20130101 LA20130915BHEP        </classification-cpc><classification-cpc mxw-id="PCL1989645821" load-source="docdb" scheme="CPC">C09J2475/006       20130101 LA20130915BHEP        </classification-cpc><classification-cpc mxw-id="PCL2032328726" load-source="docdb" scheme="CPC">A61G   7/05        20130101 FI20140221BHEP        </classification-cpc><classification-cpc mxw-id="PCL2032328727" load-source="docdb" scheme="CPC">B32B  43/00        20130101 LI20140213BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132365570" lang="DE" load-source="patent-office">KLEBEPFLASTER UND VERFAHREN ZU SEINER VERWENDUNG</invention-title><invention-title mxw-id="PT132365571" lang="EN" load-source="patent-office">ADHESIVE PATCH AND METHOD OF USING THE SAME</invention-title><invention-title mxw-id="PT132365572" lang="FR" load-source="patent-office">PIÈCE ADHÉSIVE ET PROCÉDÉ D'UTILISATION DE CELUI-CI</invention-title></technical-data><parties><applicants><applicant mxw-id="PPAR919525663" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>SURFACE MEDICAL INC</last-name><address><country>CA</country></address></addressbook></applicant><applicant mxw-id="PPAR919512156" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>SURFACE MEDICAL INC.</last-name></addressbook></applicant><applicant mxw-id="PPAR919005809" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Surface Medical Inc.</last-name><iid>101337700</iid><address><street>405, 1100 - 8th Avenue SW</street><city>Calgary, Alberta T2P 3T8</city><country>CA</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR919525641" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>COLLINS THOMAS</last-name><address><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR919523081" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>COLLINS, THOMAS</last-name></addressbook></inventor><inventor mxw-id="PPAR919018248" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>COLLINS, THOMAS</last-name><address><street>7 Elysian Crescent SW</street><city>Calgary, Alberta T3H 0E7</city><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR919514123" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>URQUHART MICHAEL DREW</last-name><address><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR919506051" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>URQUHART, Michael Drew</last-name></addressbook></inventor><inventor mxw-id="PPAR919009469" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>URQUHART, Michael Drew</last-name><address><street>8 Baycrest Place SW</street><city>Calgary, Alberta T2V 0K6</city><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR919534911" load-source="docdb" sequence="3" format="epo"><addressbook><last-name>POTTER BARBARA JEANNE LACOSTE</last-name><address><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR919533706" load-source="docdb" sequence="3" format="intermediate"><addressbook><last-name>POTTER, Barbara Jeanne LaCoste</last-name></addressbook></inventor><inventor mxw-id="PPAR919010128" load-source="patent-office" sequence="3" format="original"><addressbook><last-name>POTTER, Barbara Jeanne LaCoste</last-name><address><street>103 Hawktree Bay NW</street><city>Calgary, Alberta T3G 2X9</city><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR919517982" load-source="docdb" sequence="4" format="epo"><addressbook><last-name>SCHACTER JEFFREY MILES</last-name><address><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR919508209" load-source="docdb" sequence="4" format="intermediate"><addressbook><last-name>SCHACTER, Jeffrey Miles</last-name></addressbook></inventor><inventor mxw-id="PPAR919011792" load-source="patent-office" sequence="4" format="original"><addressbook><last-name>SCHACTER, Jeffrey Miles</last-name><address><street>27 Braemar Glen Road</street><city>Calgary, Alberta T3Z 3C9</city><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR919524605" load-source="docdb" sequence="5" format="epo"><addressbook><last-name>BURNAND SEAN PETER</last-name><address><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR919504682" load-source="docdb" sequence="5" format="intermediate"><addressbook><last-name>BURNAND, Sean Peter</last-name></addressbook></inventor><inventor mxw-id="PPAR919015999" load-source="patent-office" sequence="5" format="original"><addressbook><last-name>BURNAND, Sean Peter</last-name><address><street>6410, 1A Street SW</street><city>Calgary, Alberta T2H 0G6</city><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR919520710" load-source="docdb" sequence="6" format="epo"><addressbook><last-name>FOGEL BRUCE STEWART</last-name><address><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR919538885" load-source="docdb" sequence="6" format="intermediate"><addressbook><last-name>FOGEL, Bruce Stewart</last-name></addressbook></inventor><inventor mxw-id="PPAR919015302" load-source="patent-office" sequence="6" format="original"><addressbook><last-name>FOGEL, Bruce Stewart</last-name><address><street>24197 Westbluff Drive</street><city>Calgary, Alberta T3Z 3N9</city><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR919541802" load-source="docdb" sequence="7" format="epo"><addressbook><last-name>LAM IWAIN</last-name><address><country>CA</country></address></addressbook></inventor><inventor mxw-id="PPAR919504186" load-source="docdb" sequence="7" format="intermediate"><addressbook><last-name>LAM, Iwain</last-name></addressbook></inventor><inventor mxw-id="PPAR919017009" load-source="patent-office" sequence="7" format="original"><addressbook><last-name>LAM, Iwain</last-name><address><street>10415 Brackenridge Rd. SW</street><city>Calgary, Aberta T2W 1A1</city><country>CA</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR919011616" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Krauss, Jan</last-name><iid>100050623</iid><address><street>Boehmert &amp; Boehmert Pettenkoferstrasse 20-22</street><city>80336 München</city><country>DE</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="CA-2012000195-W"><document-id><country>CA</country><doc-number>2012000195</doc-number><kind>W</kind><date>20120305</date><lang>EN</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2012119227-A1"><document-id><country>WO</country><doc-number>2012119227</doc-number><kind>A1</kind><date>20120913</date><lang>EN</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS549779478" load-source="docdb">AL</country><country mxw-id="DS549847983" load-source="docdb">AT</country><country mxw-id="DS549863460" load-source="docdb">BE</country><country mxw-id="DS549917459" load-source="docdb">BG</country><country mxw-id="DS549767048" load-source="docdb">CH</country><country mxw-id="DS549863461" load-source="docdb">CY</country><country mxw-id="DS549849382" load-source="docdb">CZ</country><country mxw-id="DS549779479" load-source="docdb">DE</country><country mxw-id="DS549863462" load-source="docdb">DK</country><country mxw-id="DS549863463" load-source="docdb">EE</country><country mxw-id="DS549767400" load-source="docdb">ES</country><country mxw-id="DS549917460" load-source="docdb">FI</country><country mxw-id="DS549917461" load-source="docdb">FR</country><country mxw-id="DS549779480" load-source="docdb">GB</country><country mxw-id="DS549863464" load-source="docdb">GR</country><country mxw-id="DS549779493" load-source="docdb">HR</country><country mxw-id="DS549849383" load-source="docdb">HU</country><country mxw-id="DS549767057" load-source="docdb">IE</country><country mxw-id="DS549863465" load-source="docdb">IS</country><country mxw-id="DS549917462" load-source="docdb">IT</country><country mxw-id="DS549863482" load-source="docdb">LI</country><country mxw-id="DS549779494" load-source="docdb">LT</country><country mxw-id="DS549847984" load-source="docdb">LU</country><country mxw-id="DS549917463" load-source="docdb">LV</country><country mxw-id="DS549917464" load-source="docdb">MC</country><country mxw-id="DS549847985" load-source="docdb">MK</country><country mxw-id="DS549847990" load-source="docdb">MT</country><country mxw-id="DS549847991" load-source="docdb">NL</country><country mxw-id="DS549767058" load-source="docdb">NO</country><country mxw-id="DS549847992" load-source="docdb">PL</country><country mxw-id="DS549767413" load-source="docdb">PT</country><country mxw-id="DS549849144" load-source="docdb">RO</country><country mxw-id="DS549767414" load-source="docdb">RS</country><country mxw-id="DS549847993" load-source="docdb">SE</country><country mxw-id="DS549779495" load-source="docdb">SI</country><country mxw-id="DS549767059" load-source="docdb">SK</country><country mxw-id="DS549767060" load-source="docdb">SM</country><country mxw-id="DS549863483" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data><office-specific-data><eptags><ep-no-a-document-published>*</ep-no-a-document-published></eptags></office-specific-data></bibliographic-data><abstract mxw-id="PA100074291" ref-ucid="WO-2012119227-A1" lang="EN" load-source="patent-office"><p num="0000">The disclosure provides, in part, adhesive patches for repairing damaged surfaces of health care devices. In one of its aspects the disclosure provides a method of repairing the surface of health care device by applying an adhesive patch over a damaged portion of the surface, the patch comprising a film layer and an adhesive layer. In another one of its aspects, the disclosure provides an adhesive patch for repairing the surface of a health care device comprising a film layer and an adhesive layer.</p></abstract><abstract mxw-id="PA100342089" ref-ucid="WO-2012119227-A1" lang="EN" source="national office" load-source="docdb"><p>The disclosure provides, in part, adhesive patches for repairing damaged surfaces of health care devices. In one of its aspects the disclosure provides a method of repairing the surface of health care device by applying an adhesive patch over a damaged portion of the surface, the patch comprising a film layer and an adhesive layer. In another one of its aspects, the disclosure provides an adhesive patch for repairing the surface of a health care device comprising a film layer and an adhesive layer.</p></abstract><abstract mxw-id="PA100074292" ref-ucid="WO-2012119227-A1" lang="FR" load-source="patent-office"><p num="0000">La présente invention concerne, en partie, des pièces adhésives pour réparer des surfaces endommagées de dispositifs de soins. Dans un de ses aspects, la présente invention concerne un procédé de réparation de la surface de dispositif de soins par application d'une pièce adhésive sur une partie endommagée de la surface, la pièce comprenant une couche de film et une couche adhésive. Dans un autre de ses aspects, la présente invention concerne une pièce adhésive pour réparer la surface d'un dispositif de soins comprenant une couche de film et une couche adhésive.</p></abstract><abstract mxw-id="PA100342090" ref-ucid="WO-2012119227-A1" lang="FR" source="national office" load-source="docdb"><p>La présente invention concerne, en partie, des pièces adhésives pour réparer des surfaces endommagées de dispositifs de soins. Dans un de ses aspects, la présente invention concerne un procédé de réparation de la surface de dispositif de soins par application d'une pièce adhésive sur une partie endommagée de la surface, la pièce comprenant une couche de film et une couche adhésive. Dans un autre de ses aspects, la présente invention concerne une pièce adhésive pour réparer la surface d'un dispositif de soins comprenant une couche de film et une couche adhésive.</p></abstract><description mxw-id="PDES51374428" ref-ucid="WO-2012119227-A1" lang="EN" load-source="patent-office"><!-- EPO <DP n="2"/>--><p id="p0001" num="0001"> ADHESIVE PATCH AND METHOD OF USING THE SAME </p><p id="p0002" num="0002">FIELD </p><p id="p0003" num="0003">[0001] The present disclosure generally relates to adhesive patches, for example, patches for repairing damaged surfaces of health care devices. BACKGROUND </p><p id="p0004" num="0004">[0002] A typical health care device undergoes significant use and wear throughout its lifespan. Damage to the surface of the health care device, such as, tears, punctures, rips, burns, wear, cracks, and other surface damage, is unattractive, unsanitary and presents potential health risks. Increasingly, health care providers are becoming aware of the role that contaminated environmental surfaces play in the transmission of pathogens. Patient care initiatives, particularly infection control efforts, are becoming more prevalent. At least 30% of health care associated infections can be prevented by following infection prevention and control strategies (Haley RW, Culver DH, White JW, Morgan WM, et al. (1985) The nationwide nosocomial infection rate: a new need for vital statistics. Am J Epidemiol. Vol. 121 : 159-67). One challenge in cleaning or disinfecting the surfaces of health care devices is the occurrence of small tears and other damage to the surface of the device. Not only is routine cleaning of health care devices suboptimal, but damaged surfaces typically cannot be fully cleaned or disinfected thereby creating a potential reservoir for infectious agents. [0003] Health care devices used in hospital environments have been found to be a source of health care associated infections. Environmental microbiological surveys have indicated that hospital devices (for example, beds, tables, stools, wheelchairs, racks, trolleys, stretchers, mattresses, catheter-bag, and other furniture, equipment and articles used in a hospital environment) can be contaminated with pathogens at a higher incidence relative to other surfaces (see, for example, Rampling A, Wiseman S, Davis L., et al. (2001 ) Evidence that hospital hygiene is important in the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect. Vol. 49: 109-1 16; and Blythe D, Keenlyside D, Dawson SJ, Galloway A. (1998) Environmental contamination due to methicillin-resistant Staphylococcus aureus. J Hosp Infect. Vol. 38:67-70). In addition, there have been reports of hospital mattresses contaminated with infectious agents, including for example, Pseudomonas aeruginosa, methicillin- 
<!-- EPO <DP n="3"/>-->
 resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), Acinetobacter, and other fungal and viral pathogens. Hospital mattresses damaged by extensive use, tears and sharp objects, such as needles, may create a potential reservoir for infectious agents and a portal for entry and exit of infectious agents. Several studies have demonstrated that damaged mattresses have had a role in outbreaks, the transmission of disease to patients, and in some cases patient death (see Creamer E, Humphreys H. (2008) The contribution of beds to healthcare-associated infection: the importance of adequate decontamination, J Hosp Infect. Vol. 69:8-23; Sherertz RJ, Sullivan ML. ( 1985) An outbreak of infections with Acinetobactercalcoaceticus in burn patients: contamination of patients' mattresses. J Infect Dis. Vol. 151 :252-258; Moore EP, Williams EW. (1991) A maternity hospital outbreak of methicillin resistant Staphylococcus aureus. J Hosp Infect. Vol.19:5-16; Ndawula EM, Brown L. (1991) Mattresses as reservoirs of epidemicmethicillin- resistant Staphylococcus aureus. Lancet. Vol. 337:488.; Fujita K, Lilly HA, Kidson A, Ayliffe GA. (1981) Gentamicin resistant Pseudomonas aeruginosa infection from mattresses in a burns unit. Br Med J. Vol. 283:219-220; Robertson MH, Hoy G, Peterkin IM. (1980) Anti-static mattress as a reservoir of pseudomonas infection. Br Med J. Vol. 280:831-832; and O'Donoghue MA, Allen KD. (1992) Costs of an outbreak of wound infection in an orthopaedic ward. J Hosp Infect. Vol. 22:73-79). These studies discuss that damaged hospital mattresses may harbour infectious agents and result in nosocomial infections, and intact mattresses or health care devices are preferred for appropriate cleaning, disinfection and infection prevention and control. </p><p id="p0005" num="0005">[0004] As a result, many health care providers have instituted policies requiring the replacement of health care devices having damaged surfaces or the replacement of the damaged components of the device. However, replacement of a health care device or its damaged components can be costly, may result in equipment downtime, and the likelihood of a tear or other surface damage occurring after replacement is high. Thus many health care devices are left in a damaged state. </p><p id="p0006" num="0006">[0005] Prior art solutions exist to repair damaged surfaces of a variety of non- medical devices, in one solution, ready-mix glue is applied to the damaged portion of the surface. However, this solution tends to be messy, leaves the surface temporarily out of service, and may create toxic fumes or be toxic through direct contact. In 
<!-- EPO <DP n="4"/>-->
 another solution, duct or other types of tape are applied to the damaged portion of the surface. However, the edges of the tape tend to breakdown after extended use or following the application of liquids or body fluids. These edges can be difficult to clean properly, thereby, creating an additional potential reservoir for infectious agents. SUMMARY </p><p id="p0007" num="0007">[0006] The disclosure provides, at least in part, adhesive patches for repairing damaged surfaces of health care devices. </p><p id="p0008" num="0008">[0007] In certain aspects the disclosure provides a method of repairing the surface of health care device by applying an adhesive patch over a damaged portion of the surface, the patch comprising a film layer and an adhesive. In certain aspects, the disclosure provides an adhesive patch for repairing the surface of a health care device comprising a film layer and an adhesive. </p><p id="p0009" num="0009">[0008] The film layer may comprise one or more of the following properties: adhesion or bonding to the adhesive or interlayer, anti-decubitus, heat-resistance, resistance to ultraviolet radiation, durability, flexibility, stretchable, breathability, cleanability, resistance to chemical cleaning products; anti-microbial properties, hypoallergenic and non-cytotoxic properties. </p><p id="p0010" num="0010">[0009] The adhesive may comprise one or more of the following properties: adhesion to film layer or interlayer and device surface, heat-resistance, pressure- resistance, resistance to ultraviolet radiation, durability, flexibility, cleanability, resistance to chemical cleaning products; plasticizer resistant, anti-microbial, hypoallergenic and non-cytotoxic properties. </p><p id="p0011" num="0011">[0010] As used herein, the term 'patch' refers to articles having a size and adhesion characteristics suitable for affecting a durable repair to health care devices such as, for example, mattresses used in hospital beds. In certain embodiments, the patches are generally planar in shape with a film layer and an adhesive layer. </p><p id="p0012" num="0012">[001 1 ] As used herein, "a" or "an" means "at least one" or "one or more". </p><p id="p0013" num="0013">[0012] This summary does not necessarily describe all features of the invention. Other aspects, features and advantages of the invention will be apparent to 
<!-- EPO <DP n="5"/>-->
 those of ordinary skill in the art upon review of the following description of specific embodiments of the invention. </p><p id="p0014" num="0014">BRIEF DESCRIPTION OF THE DRAWINGS </p><p id="p0015" num="0015">[0013] Figure 1A is a top plan view of a health care device having a damaged surface. </p><p id="p0016" num="0016">[0014] Figure IB is a side elevation view of the health care device shown in Figure I B. </p><p id="p0017" num="0017">[0015] Figure 2A is a top plan view of the health care device shown in Figures 1A and 1 B having an adhesive patch applied to the damaged portion of the surface of the health care device. </p><p id="p0018" num="0018">[0016] Figure 2B is a side elevation view of the health care device shown in Figures 1A and IB having an adhesive patch applied to the damaged portion of the surface of the health care device. </p><p id="p0019" num="0019">[0017] Figure 3 A is top plan view of the patch shown in Figures 2 A and 2B. [0018] Figure 3B is side elevation view of the patch shown in Figures 2A and 2B. DETAILED DESCRIPTION </p><p id="p0020" num="0020">[0019] The present adhesive patches comprise a film layer and an adhesive. </p><p id="p0021" num="0021">[0020] The film layer may be any suitable substance. For example, the film layer may comprise a thermoplastic or thermosetting polymer or a combination of polymers. Examples of thermoplastic polymers include, but are not limited to, polyacetals, polyolefins, polyacrylics, polycarbonates, polystyrenes, polyesters, polyamides, polyvinyl, polysulfonates, polysulfides, polythioesters, polysulfones, polysulfonamides, polyureas, polyurethane, or the like, and combinations thereof. The present film layer may comprise a polyethylene, polyurethane, polypropylene, nylon, silicone, polyamide, polyester, polyvinyl, or the like, or combinations thereof. Preferably the film layer comprises a polyvinyl, polyurethane, or the like. Such films are available commercially from a variety of sources, such as, for example Dartex Coatings Inc. (Nottingham, UK), DermaMed Coatings Company LLC. (Ohio, USA), 
<!-- EPO <DP n="6"/>-->
 Argotec Inc. (Massachusetts, USA), Flexcon Inc. (Massachusetts, USA), ETC Technologies Inc. (Massachusetts, USA), and Medical Adhesive Tape Technologies Inc. (New York, USA). Films available from Dartex Coatings may include, but not limited to, DartexTC84. Films available from DermaMed Coatings Company may include, but not limited to, DermaMed4mil PU. Films available from Argotec may include, but not limited to, Argotec2mil PU. Films available from Flexcon may include, but not limited to, FlexconV400 and V600. Films available from ETC Technologies may include, but not limited to, ETC 2 mil, 3 mil, 4 mil, and 6 mil. Films available from Medical Adhesive Tape Technologies may include, but not limited to, M.A.T.T. 2.5GA PU, M.A.T.T. 3.0GA Vinyl, and M.A.T.T. 3.5GA vinyl. The film layer may be non-cytotoxic, hypoallergenic, resistant to bacterial growth, or a combination thereof. The film layer may have a dyne level of 36 dynes/cm or greater, 37 dynes/cm or greater, 38 dynes/cm or greater, 39 dynes/cm or greater, 40 dynes/cm or greater, for the side that will come into contact with the adhesive in the final construction. </p><p id="p0022" num="0022">[0021 ] Any suitable adhesive may be used herein. For example, pressure-sensitive adhesives (PSA), permanent adhesives, adhesives that cure with time, light-activated adhesives that cure with electromagnetic energy such as UV or visible light, or heat- activated adhesives may be used. The adhesive may be non-cytotoxic, hypoallergenic, resistant to bacterial growth, or a combination thereof. The adhesive may be in the form of an adhesive layer. </p><p id="p0023" num="0023">[0022] A pressure-sensitive adhesive may comprise polyurethane, silicone polymer, or other synthetic polymer based adhesive, and may or may not be cross- linked. Adhesives are available commercially from, for example, Adchem Inc. (New York, USA), 3M Canada Inc. (Ontario, Canada). Flexcon Inc. (Massachusetts, USA), and Medical Adhesive Tape Technologies Inc. (New York, USA). Adhesives from Adchem may include, but not limited to, Adchem 7833, Adchem 653, Adchem 7603, Adchem 7854, Adchem 7333 and Adchem 730. Adhesives from 3M may include, but not limited to, 3M9465. Adhesives from Flexcon may include, but not limited to, Flexmark TT200. Adhesives from Medical Adhesive Tape Technologies may include, but not limited to, COL-RZ002, COL-ACR003 and COL-ACR007. 
<!-- EPO <DP n="7"/>-->
 [0023] In certain aspects, the present patches preferably are able to elongate at least 30%. For example, 31% or more, 32% or more, 33% or more, 34% or more, 35% or more, 36% or more, 37% or more, 38% or more, 39% or more, 40% or more. While not wishing to be bound by theory it is believed that the ability to elongation reduces the risk of peeling or separation from the surface of the medical device while in use. Peeling or separation could reduce the efficacy of cleaning and/or disinfection procedures thus creating a potential reservoir for pathogens. The average of elongation may be measured by any suitable method such as, for example, ASTM D882. [0024] In certain aspects, the present patches preferably have an average edge thickness of 10 mil or less, such as 9 mil or less, 8 mil of less, 7 mil or less, 6 mil or less. While not wishing to be bound by theory it is believed that thicker patches can present a risk of peeling or separation from the surface occurring. Peeling or separation could reduce the efficacy of cleaning and/or disinfection procedures thus creating a potential reservoir for pathogens. The edge thickness may be measured by any suitable method such as, for example, using thickness gauges available from Mitutoyo or Mahr. </p><p id="p0024" num="0024">[0025] In certain aspects, the present patches preferably have an adhesion value of at least about 2.5 lbs/inch for at least 7 days after application wherein the temperature is 16-21 °C and the relative humidity is 15-50%. For example, the adhesion value may be 2.6 lbs/inch, 2.7 lbs/inch, 2.8 lbs/inch, 2.9 lbs/inch, 3.0 lbs/inch. While not wishing to be bound by theory it is believed that patches with lower adhesion values can present a risk of peeling or separation from the surface occurring. Peeling or separation could reduce the efficacy of cleaning and/or disinfection procedures thus creating a potential reservoir for pathogens. The adhesion value may be measured by any suitable method such as, for example, ASTM D3330 or PSTC-101. </p><p id="p0025" num="0025">[0026] Health care devices may be subjected to cleaning and disinfection via a number of methods. For example, mattresses on hospital beds may be cleaned with compositions comprising hydrogen peroxide, sodium hypochlorite, ammonium-based cleaning compositions, isopropanol, or the like. In certain embodiments, the present patches are resistant to one or more of such compositions. That is, the performance of 
<!-- EPO <DP n="8"/>-->
 the patches in situ is not significantly affected by transitory but repeated exposure to the cleaning solution. </p><p id="p0026" num="0026">[0027] The present patches may be provided in any suitable shape such as, for example, square, rectangle, circle, oval, rhomboid, cross, or the like. The present patches may be provided in a roll or sheet form. In certain embodiments the patch may be trimmed to the desired size before application. The present patches may be provided in any suitable size. For example, the maximum diameter of the present patches may be 1 cm or more, 2 cm or more, 3 cm or more, 4 cm or more, 5 cm or more, 6 cm or more, 7 cm or more, 8 cm or more, 9 cm or more, 10 cm or more, 1 1 cm or more, 12 cm or more, 13 cm or more, 14 cm or more, 15 cm or more. The maximum diameter of the present patches may be 100 cm or less, 95 cm or less, 90 cm or less, 85 cm or less, 80 cm or less, 75 cm or less. </p><p id="p0027" num="0027">[0028] The present patches may comprise an anti-microbial agent. As used herein, the term "anti-microbial" means the reduction or inhibition of microbial bioburden, colonization, or attachment by microbial organisms. Antimicrobial agents include but not limited to, antibiotics, antiseptics, biocides, or other antimicrobial compounds, such as, for example, silver, silver nanoparticles, ionic silver, combinations of one or more one silver compounds, other metals such as zinc, copper, gold, platinum, and their salts or complexes, for example, zinc undecylenate, quaternary ammonium salts, isoniazid, ethambutol, pyrazinamide, streptomycin, clofazimine, rifabutin, fluoroquinolones, ofloxacin, sparfloxacin, rifampin, azithromycin, clarithromycin, dapsone, tetracycline, erythromycin, ciprofloxacin, doxycycline, ampicillin, amphotericin B, ketoconazole, fluconazole, pyrimethamine, sulfadiazine, clindamycin, lincomycin, pentamidine, atovaquone, paromomycin, diclazaril, acyclovir, trifluorouridine, foscarnet, penicillin, gentamicin, ganciclovir, iatroconazole, miconazole, Zn-pyrithione, chlorohexidine, polyhexamethylenebiguanides, polyhexamethylenebiguanides, triclosan, iodine, iodinepolyvinylpyrrolidone complex, urea-peroxide complex, benzalkonium salts, quaternary ammonium compounds based on saccharinate, algaecides, carbamates, cyanates, turmeric extract, other natural anti-infective compounds and combinations thereof. Anti-microbial agents may be effective against one or more bacteria from the genus Bordetella, Borrelia, Brucella, Campylobacter, Chlamydia, Chlamydophilia, 
<!-- EPO <DP n="9"/>-->
 Clostridium, Corynebacterium, Enterococcus, Escherichia, Francisella, Haemophilus, Helicobacter, Legionella, Leptospira, Listeria, Mycobacterium, Mycoplasma, Neisseria, Pseudomonas, Rickettsia, Salmonella, Shigella, Staphylococcus, Streptococcus, Treponema, Vibrio, and/or Yersinia. For example, Bordetella pertussis, Borrelia burgdorferi, Brucella abortus, Brucella canis, Brucella melitensis, Brucella suis, Campylobacter jejuni, Chlamydia pneumoniae, Chlamydia trachomatis, Chlamydophila psittaci, Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Clostridium tetani, Corynebacterium diphtheriae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Francisella tularensis, Haemophilus influenzae, Helicobacter pylori, Legionella pneumophila, Leptospira interrogans, Listeria monocytogenes, Mycobacterium leprae, Mycobacterium tuberculosis, Mycobacterium ulcerans, Mycoplasma pneumoniae, Pseudomonas aeruginosa, Rickettsia rickettsii, Salmonella typhi, Salmonella typhimurium, Shigella sonnei, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus saprophytics, Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, Treponema pallidum, Vibrio cholerae, Yersinia pestis, and the like. It is preferred that the present anti-microbial agent be efficacious against Escherichia coli, Legionella pneumophila, Streptococcus pneumoniae, Streptococcus pyogenes, and the like. </p><p id="p0028" num="0028">[0029] The present patches may contain an interlayer film to enhance the rigidity and handling of the invention. This interlayer can be, but not limited to, polyurethane, polyvinyl, polyester, kraft paper, or the like. Such films are available commercially from Adhesive Films. Inc. (New Jersey, USA). Examples from Adhesive films may include, but not limited to, UAF-472 1 mil, UAF-472 2 mil, and PAF-1 10 2 mil. </p><p id="p0029" num="0029">[0030] The present patches may comprise a release liner and/or a transfer liner on the film layer and/or adhesive layer to protect the patch before use. Such liners may also improve the ease of handling of the patch prior to application to device. </p><p id="p0030" num="0030">[0031] Referring to Figures 1A and IB, an embodiment of a health care device 10 is shown. The health care device 10 may be any device used in a health care environment, such as, for example, beds, tables, stools, wheel chairs, racks, trolleys, stretchers, mattresses, catheter-bags, and other furniture, equipment and articles used in a health care environment. The device 10 generally comprises a surface layer 12 and a supporting layer 14. The surface layer 12 defines at least a portion of the outer 
<!-- EPO <DP n="10"/>-->
 surface of the device 10 that may be subject to contact with a person during the use of the device 10. The surface layer 12 may be comprised of any material suitable for a health care environment, such as, for example, while not limited to, nylon, silicone, polyurethane, polyvinyl, polyethylene, polyamides and polyesters. The supporting layer 14 supports the surface layer 12 and may be comprised of any material suitable to provide structural support to the surface layer 12, such as, for example, while not limited to, foam, wood, cotton, plastics, and metals. In the alternative, the device 10 may not comprise a supporting layer 14. </p><p id="p0031" num="0031">[0032] Figures 1A and IB depict a damaged portion 20 of the surface layer 12. The damaged portion 20 may comprise one or more tears, punctures, rips, burns, wear, cracks, and other damage to the surface layer 12. As discussed above, damaged portions 20 of surface layers 12 in health care devices 10 are unattractive, unsanitary and present potential health risks by creating a host or reservoir for infectious agents. </p><p id="p0032" num="0032">[0033] Referring to Figures 2A and 2B, one embodiment of an adhesive patch 30 for repairing damaged surfaces of a health care device 10 is shown. The patch 30 is applied to the surface layer 12 of the device 10 to cover the damaged portion 20 and adhere to the surface layer 12. The patch 30 is configured to be suitable for application in health care environments. In particular, amongst other suitable properties for a health care environment, the patch 30 may comprise one or more of the following properties: physical properties, including, adhesion, anti-decubitus, heat-resistance, resistance to ultraviolet radiation, durability, flexibility, stretchable, breathability, cleanability, resistance to chemical cleaning products; anti-microbial properties, hypoallergenic and non-cytotoxic properties. The patch 30 comprises an adhesive layer 34 and a film layer 32. [0034] Referring to Figures 3A and 3B, the patch 30 generally comprises a film layer 32, a peel-off layer 36, and an adhesive layer 34 disposed in between the film layer 32 and peel-off layer 36. Prior to application of the patch 30 to a health care device 10, the adhesive layer 34 functions to adhere the film layer 32 and peel-off layer 36 into a unitary patch 30. The film layer 32 and peel-off layer 36 protect the adhesive layer 34 and prevent the adhesive layer 34 from adhering to other objects. During application of the patch 30 to the device 10, the peel-off layer 36 is removed from the patch 30 and the adhesive layer 34 functions to adhere the film layer 32 to 
<!-- EPO <DP n="11"/>-->
 the surface layer 12 of the device 10. The adhesive layer 34 may be comprised of any suitable adhesive suitable for a health care environment, such as, for example, acrylic, silicone. In particular, amongst other suitable properties for a health care environment, the adhesive layer 34 may comprise one or more of the following properties: physical properties, including, adhesion to film layer and device surface, heat-resistance, pressure-resistance, resistance to ultraviolet radiation, durability, flexibility, cleanability, resistance to cleaning products, plasticizer resistant, anti-microbial properties, hypoallergenic and non-cytotoxic properties. </p><p id="p0033" num="0033">[0035] The film layer 32 comprises a top surface 42 and a bottom surface 44. The top surface 42 is an externally facing surface that may be subject to contact with a person during use of the device 10; while the bottom surface 44 is an interior surface that is adhered by the adhesive layer 34, adhesive layer 34, adhesive layer 34 is also adhered to the top layer 46 of the peel-off layer 36, which prior to application of the patch 30 to the device 10 the peel-off-layer 36 is removed from the adhesive layer 34, and is adhered by the adhesive layer 34 to the surface layer 12 of the device 10 during application of the patch 30 to the device 10. The film layer 32 may be comprised of any material suitable for a health care environment, such as, for example, nylon, silicone, polyurethane, polyvinyl, polyethylene, polyamides and polyesters. In particular, amongst other suitable properties for a health care environment, the film layer 32 may comprise one or more of the following properties: physical properties, including, adhesion or bonding to the adhesive, anti-decubitus, heat-resistance, resistance to ultraviolet radiation, durability, flexibility, stretchable, breathability, cleanability, resistance to chemical cleaning products; anti-microbial properties, hypoallergenic and non-cytotoxic properties. [0036] The peel-off layer 36 comprises a top surface 46 and a bottom surface 48. The top surface 46 is an internal surface that is adhered by the adhesive layer 34 to the bottom surface 44 of the film layer 32, prior to application of the patch 30 to the device 10 and peel-off layer 36 is removed from top surface 46 during application of the patch 30 to the device 10. The peel-off layer 36 may be comprised of any material suitable to be removably adhered to the film layer 32 by the adhesive layer 34, such as, for example, kraft paper or polyester. 
<!-- EPO <DP n="12"/>-->
 [0037] The present disclosure provides health care devices comprising a patch according to the present invention. The present disclosure provides a mattress comprising a patch according to the present invention. </p><p id="p0034" num="0034">[0038] The present disclosure provides the use of a patch as described herein for repairing the surface of a health care device such as a mattress. Said use comprises applying the patch over the damaged portion of the surface of the health care device. </p><p id="p0035" num="0035">[0039] The present disclosure provides a method of repairing the surface of health care device by applying a patch according to the present invention over a damaged portion of the surface. The patch may comprising a film layer and an adhesive layer. The patch may comprise an anti-microbial agent. The patch may comprise one or more of the following properties: adhesion, heat-resistance, pressure-resistance, resistance to ultraviolet radiation, durability, flexibility, cleanability, resistance to cleaning products; anti-microbial, wound healing, hypoallergenic and non-cytotoxic properties. The film layer may comprise a polyvinyl, polyurethane, or the like. The adhesive layer may comprise an acrylic, silicone, or the like. The patch may comprise a peel-off layer removably adhered to the film layer by the adhesive layer. </p><p id="p0036" num="0036">[0040] It is contemplated that the different parts of the present description may be combined in any suitable manner. For instance, the present examples, methods, aspects, embodiments or the like may be suitably implemented or combined with any other embodiment, method, example or aspect of the invention. </p><p id="p0037" num="0037">[0041 ] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as is commonly understood by one of ordinary skill in the art to which this invention belongs. Unless otherwise specified, all patents, applications, published applications and other publications referred to herein are incorporated by reference in their entirety. If a definition set forth in this section is contrary to or otherwise inconsistent with a definition set forth in the patents, applications, published applications and other publications that are herein incorporated by reference, the definition set forth in this section prevails over the definition that is incorporated herein by reference. Citation of references herein is not to be construed nor considered as an admission that such references are prior art to the present invention. 
<!-- EPO <DP n="13"/>-->
 [0042] Use of examples in the specification, including examples of terms, is for illustrative purposes only and is not intended to limit the scope and meaning of the embodiments of the invention herein. Numeric ranges are inclusive of the numbers defining the range. In the specification, the word "comprising" is used as an open- ended term, substantially equivalent to the phrase "including, but not limited to," and the word "comprises" has a corresponding meaning. </p><p id="p0038" num="0038">[0043] The invention includes all embodiments, modifications and variations substantially as hereinbefore described and with reference to the examples and figures. It will be apparent to persons skilled in the art that a number of variations and modifications can be made without departing from the scope of the invention as defined in the claims. Examples of such modifications include the substitution of known equivalents for any aspect of the invention in order to achieve the same result in substantially the same way. </p><p id="p0039" num="0039">[0044] The present invention will be further illustrated in the following examples. However it is to be understood that these examples are for illustrative purposes only, and should not be used to limit the scope of the present invention in any manner. </p><p id="p0040" num="0040">EXAMPLES </p><p id="p0041" num="0041">[0045] 28 different prototypes were developed based on a combination of 13 commercially available film layers and 9 commercially available adhesives layers. These prototypes were evaluated for their suitability in repairing damaged portions of the surfaces of health care devices. The film and adhesive layers were combined using standard manufacturing techniques. </p><p id="p0042" num="0042">[0046] Patches were evaluated for their ability to withstand standard hospital cleaning products. [0047] Table 1 compares patch (Dartex + acrylic PSA, 3M and Adchem) relative to other tested compositions and that which is commercially available (Tear-Aid). Physical damages (cracking, shrinking, wrinkling) was observed for the material tested after 1 hour of immersion in the four chemicals (5.5% Sodium Hypochlorite, 7% Hydrogen Peroxide, 70% Isopropanol, Ammonium Chloride) 
<!-- EPO <DP n="14"/>-->
 TABLE 1 </p><p id="p0043" num="0043"> Adhesion Failure before 60mins </p><p id="p0044" num="0044"><img id="imgf000014_0001" he="117" wi="142" file="imgf000014_0001.tif" img-format="tif" img-content="table" orientation="portrait" inline="no"/></p><p id="p0045" num="0045">The patch may comprise an antimicrobial additive. Table 2 summarizes the presence or absence of an additive for a sample of patches. TABLE 2 </p><p id="p0046" num="0046"><img id="imgf000014_0002" he="79" wi="131" file="imgf000014_0002.tif" img-format="tif" img-content="table" orientation="portrait" inline="no"/><!-- EPO <DP n="15"/>-->
 Duct Tape (8 mil) </p><p id="p0047" num="0047">The adhesive is preferably non-cytotoxic, hypoallergenic, and/or resistant to microbial growth. Table 4 summarizes these characteristics for certain adhesives. </p><p id="p0048" num="0048">TABLE 4 </p><p id="p0049" num="0049"><img id="imgf000015_0001" he="104" wi="132" file="imgf000015_0001.tif" img-format="tif" img-content="table" orientation="portrait" inline="no"/></p><p id="p0050" num="0050">The film layer is preferably non-cytotoxic, hypoallergenic, and/or resistant to microbial growth. Table 5 summarizes these characteristics for certain films. </p><p id="p0051" num="0051">TABLE 5 </p><p id="p0052" num="0052"><img id="imgf000015_0002" he="68" wi="131" file="imgf000015_0002.tif" img-format="tif" img-content="table" orientation="portrait" inline="no"/><!-- EPO <DP n="16"/>-->
 Argotex2mil No </p><p id="p0053" num="0053"> FlexconV400 / V600 No </p><p id="p0054" num="0054"> Sample Microbial Growth* </p><p id="p0055" num="0055"> S aureus P aeruginosa Abrasiliensis</p><p id="p0056" num="0056">Control Heavy Growth Heavy Growth Heavy Growth</p><p id="p0057" num="0057">DartextTC84 No Growth No Growth Minimal Growth</p><p id="p0058" num="0058">Tear-Aid No Growth No Growth Minimal Growth</p><p id="p0059" num="0059">* microbial growth rate of less than 10% based on test standard ASTM G21 </p><p id="p0060" num="0060">The adhesion value of the patch to the device is preferably 2.5 lbs / inch or greater 7 days after application at 16-21°C and relative humidity of 15-50% relative humidity. Table 6 summarizes the performance of certain patches. </p><p id="p0061" num="0061">TABLE 6 </p><p id="p0062" num="0062"><img id="imgf000016_0001" he="62" wi="142" file="imgf000016_0001.tif" img-format="tif" img-content="table" orientation="portrait" inline="yes"/></p><p id="p0063" num="0063">In summary, 2 samples made from the film Dartex TC84 and the adhesive Adchem 7833 or 3M9465 were found to perform best against a variety of criteria required to be a function patch for the repair and regeneration of surface integrity on mattresses or other planar surfaces in a health care environment. 
</p></description><claims mxw-id="PCLM44999047" ref-ucid="WO-2012119227-A1" lang="EN" load-source="patent-office"><claim id="clm-0001" num="0001"><!-- EPO <DP n="17"/>--><claim-text/><claim-text>A repair patch for health care devices, said patch comprising a film layer and an adhesive wherein the patch has an average edge thickness of 10 mil or less. </claim-text><claim-text>A repair patch for health care devices, said patch comprising a film layer and an adhesive wherein the patch has an average of elongation of 30% or greater. </claim-text><claim-text>A repair patch for health care devices, said patch comprising a film layer and an adhesive wherein the patch has an adhesion value of at least about 2.5 lbs/inch. </claim-text><claim-text>A patch according to any of claims 1 to 3, comprising an antimicrobial agent. </claim-text><claim-text>A patch according to any of claims 1 to 4, wherein the film layer comprises polyethylene, polyurethane, polypropylene, nylon, silicone, polyamide, polyester, polyvinyl, or a combination thereof. </claim-text><claim-text>A patch according to any of claims 1 to 5, wherein the film layer comprises polyvinyl, polyurethane, or a combination thereof. </claim-text><claim-text>A patch according to any of claims 1 to 6, wherein the adhesive is a pressure- sensitive adhesive. </claim-text><claim-text>A patch according to any of claims 1 to 7, wherein the adhesive is comprised within an adhesive layer. </claim-text><claim-text>A patch according to any of claims 1 to 7, wherein the adhesive is comprised within an adhesive layer and the layer comprises acrylic. </claim-text><claim-text>A patch according to any of claims 1 to 9, wherein the patch comprises a film layer and an adhesive layer, each layer having an average thickness of from 1 to 9 mils, wherein the average thickness of the two layers does not exceed 10 mils. </claim-text><claim-text>A patch according to any of claim 1 to 10, wherein the health care device is a mattress. 
<!-- EPO <DP n="18"/>-->
</claim-text><claim-text>12. Use of a patch according to any of claims 1 to 1 1 for the repair of a health care device. </claim-text><claim-text>13. A health care device comprising a patch according to any of claims 1-1 1. </claim-text><claim-text>14. A method of repairing a health care device, said method comprising providing a patch according to any of claims 1 to 10 and adhering said patch to said health care device. </claim-text><claim-text>15. The method of claim 14 wherein the health care device is a mattress. 
</claim-text></claim></claims><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
